TXMD Press Releases

TherapeuticsMD to Host Second Quarter 2015 Financial Results Conference Call and Webcast August 6
27 July 2015

THERAPEUTICSMD ANNOUNCES PRICING OF COMMON STOCK OFFERING
9 July 2015

TherapeuticsMD Completes Enrollment in The Rejoice Trial, a Phase 3 Clinical Trial of TX-004HR (estradiol in VagiCap™)
9 June 2015

Click here for all press releases
Investor Information
Click here to become a more informed investor and learn more about investing in TXMD.
<
Industry News